The distribution of CA19-9 levels mirrored that of CEA, with levels in the SCLC and NSCLC groups significantly higher than those in the PN and NC groups (p < 0.01, Fig. 1E). This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.